The National MS Society’s Corporate Pharmaceutical Roundtable serves as a forum for engagement of corporate pharmaceutical partners and the National MS Society. Members of the Roundtable contribute to direct and focused dialogue with the purpose of collaborating on shared interests as well as addressing issues that directly impact the MS community.
The Corporate Pharmaceutical Roundtable was developed with the goal to enhance collective impact through a common vision, shared resources, and continued commitment to ensure people affected by MS can live their best lives as we stop MS in its tracks, restore what has been lost and end MS forever.
Each year, members of the Corporate Pharmaceutical Roundtable work collaboratively to develop an action plan or work toward a solution based on an identified topic and/or issue within the MS community.
Members of the Corporate Pharmaceutical Roundtable will include representatives from pharmaceutical organizations who have a shared commitment to all those affected by MS.
Members contribute to discussions by providing feedback, organizational focus, relevant non-proprietary information and contribute to actionable outcomes tasked by the Roundtable.
For more information on membership, please contact us.
2020 Corporate Pharmaceutical Roundtable Members coming soon